Financials

  • Market Capitalization 480.69 M
  • Employee 40
  • Founded 2022
  • CEO N/A
  • Website www.zurabio.com
  • Headquarter Cayman Islands
  • FIGI UNKNOWN
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-4.94
Rapporto prezzo/fatturato
100.37

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2946
KYTX
Kyverna Therapeutics, Inc. - Common Stock
7.94 USD+2.19%-16.77%-2.58%+103.59%482.71 M USD
2948
STTK
Shattuck Labs, Inc. - Common Stock
6.29 USD-2.18%-13.24%+34.69%+706.41%482.32 M USD
2953
SGMT
Sagimet Biosciences Inc. - Series A Common Stock
7.76 USD+8.53%+0.91%+22.59%-19.17%479.19 M USD
2965
PROK
ProKidney Corp. - Class A Ordinary Shares
1.55 USD-3.73%-20.10%-6.63%-25.48%468.19 M USD

Notizie